News

Back News

Emyria’s Managing Director speaks on the obstacles within the industry

Our Managing Director, Michael Winlo shining a spotlight on obstacles within the industry, why TGA registration must be the ambition for producers and how our team at Emyria are striving to make a difference.

“Clinics and data-backed medicinal cannabis firm Emyria has embarked on a drug-development program of its own. Here, chief executive Dr Michael Winlo tells Cannabiz that TGA registration must be the ambition for producers, and suggests why some may be unwilling to invest in research.”

Read the full Cannabiz article here 

Call 08 6559 2800Contact